AA Financial Advisors
VRTX icon

AA Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

AA Financial Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$415K Buy
794
+15
+2% +$7.68K 0.05% 173
2026
Q2 		$387K Sell
779
-140
-15% -$62K 0.05% 170
2026
Q1 		$410K Buy
919
+73
+9% +$34K 0.06% 155
2025
Q4 		$384K Buy
846
+85
+11% +$36.6K 0.07% 147
2025
Q3 		$298K Buy
761
+129
+20% +$53.9K 0.06% 154
2025
Q2 		$281K Buy
+632
New +$291K 0.06% 157

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

AA Financial Advisors's VRTX Position: Q3 2026 in Review

AA Financial Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 1.9% in Q3 2026, buying an estimated $7.68K and bringing the position to 794 shares worth $415K. The position accounts for 0.05% of the portfolio, ranked #173.

AA Financial Advisors first reported a position in VRTX in Q2 2025 and has held it in 6 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • AA Financial Advisors held 794 shares of Vertex Pharmaceuticals worth $415K as of Q3 2026.
  • AA Financial Advisors bought 15 Vertex Pharmaceuticals shares in Q3 2026, an estimated $7.68K.
  • Vertex Pharmaceuticals made up 0.05% of AA Financial Advisors's portfolio in Q3 2026, its #173 holding.
  • AA Financial Advisors first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on AA Financial Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.